Search Results Search Sort by RelevanceMost Recent Case and Commentary May 2002 Drug Marketing and Patient Consent Erica Ozanne Linden, JD, MPH An ethical case describes the use of a pharmacy's database to market directly to their patients without either patient consent or disclosure of the marketing intent of the materials they received. Virtual Mentor. 2002;4(5):136-137. doi: 10.1001/virtualmentor.2002.4.5.hlaw1-0205. Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 1 Amy Haddad, PhD, RN An ethical case explores the costs of prescription drugs and co-pays for patients who can't afford them. Virtual Mentor. 2002;4(11):320-323. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211. Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 2 Audiey Kao, MD, PhD An ethical case explores the costs of prescription drugs and co-pays for patients who can't afford them. Virtual Mentor. 2002;4(11):324-326. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211. Case and Commentary Aug 2024 How Should MLP Clinicians and Attorneys Help Veterans Secure Disability Benefits When Health Records Documentation Is Insufficient? Cynthia Geppert, MD, PhD, DPS, MA, MPH, MSB, MSJ, HEC-C MLPs in the VHA help minimize ethical tensions that tend to come up when diagnosing and documenting disability. AMA J Ethics. 2024;26(8):E616-621. doi: 10.1001/amajethics.2024.616. State of the Art and Science Aug 2024 How Should We Measure Effectiveness of Medical-Legal Partnerships? Prashasti Bhatnagar, JD, MPH, Deborah F. Perry, PhD, and Margaret E. Greer, MS The evidence base for “patients-to-policy” work in MLPs shows benefits to patients, clinicians, and hospital and legal systems. AMA J Ethics. 2024;26(8):E626-633. doi: 10.1001/amajethics.2024.626. Pagination First page « First Previous page ‹ Previous … Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Current page 22
Case and Commentary May 2002 Drug Marketing and Patient Consent Erica Ozanne Linden, JD, MPH An ethical case describes the use of a pharmacy's database to market directly to their patients without either patient consent or disclosure of the marketing intent of the materials they received. Virtual Mentor. 2002;4(5):136-137. doi: 10.1001/virtualmentor.2002.4.5.hlaw1-0205.
Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 1 Amy Haddad, PhD, RN An ethical case explores the costs of prescription drugs and co-pays for patients who can't afford them. Virtual Mentor. 2002;4(11):320-323. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211.
Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 2 Audiey Kao, MD, PhD An ethical case explores the costs of prescription drugs and co-pays for patients who can't afford them. Virtual Mentor. 2002;4(11):324-326. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211.
Case and Commentary Aug 2024 How Should MLP Clinicians and Attorneys Help Veterans Secure Disability Benefits When Health Records Documentation Is Insufficient? Cynthia Geppert, MD, PhD, DPS, MA, MPH, MSB, MSJ, HEC-C MLPs in the VHA help minimize ethical tensions that tend to come up when diagnosing and documenting disability. AMA J Ethics. 2024;26(8):E616-621. doi: 10.1001/amajethics.2024.616.
State of the Art and Science Aug 2024 How Should We Measure Effectiveness of Medical-Legal Partnerships? Prashasti Bhatnagar, JD, MPH, Deborah F. Perry, PhD, and Margaret E. Greer, MS The evidence base for “patients-to-policy” work in MLPs shows benefits to patients, clinicians, and hospital and legal systems. AMA J Ethics. 2024;26(8):E626-633. doi: 10.1001/amajethics.2024.626.